Efficacy claim evaluation rules take effect: A breakout playbook for smaller brands

Efficacy claim evaluation rules take effect has been gaining momentum. Data shows that in Q1, market size grew yoy by RMB 4.1bn, and industry attention is clearly rising. This piece breaks down a breakout playbook for smaller brands using public information and platform data.

Supply-side changes are equally visible. One Leaf’s layout in the Middle East, together with pricing from new entrants, is driving this round of adjustment — and concentration is moving with it.

Two signals stand out from One Leaf’s latest moves: resources keep concentrating at the top, while incremental markets like the Middle East gain bargaining power.

For practitioners, three directions follow: differentiate product and content back to R&D and supply chain; build localisation capability for markets such as the Middle East; and treat compliance and data capability as the new moat.

Bottom line: efficacy claim evaluation rules take effect is moving from concept to execution — a breakout playbook for smaller brands. Brands should review strategy before Q1 and prioritise channels and segments with higher certainty.

Related